Ever since I learned about a new treatment for neuropathy at the annual convention of the American Diabetes Association in June, I have been trying to think of a good reason why not to write about it. I failed.
As a journalist, I am naturally skeptical. As Louis Menard wrote in the current issue of The New Yorker, “A person whose financial requirements are modest and whose curiosity, skepticism, and indifference to reputation are outsized is a person at risk of becoming a journalist.”...
As a journalist, I am naturally skeptical. As Louis Menard wrote in the current issue of The New Yorker, “A person whose financial requirements are modest and whose curiosity, skepticism, and indifference to reputation are outsized is a person at risk of becoming a journalist.”...
